The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Bristol-Myers: A good buyout target?

 Mar 17, 2009 09:15 PM UTC
Return Risk
+5.39% MID
Tracked Blogger
Symbol Sentiment Start Return Closed
BMY Positive 03/17/09 -5.96% 05/07/09

Graphic_arrow1 Via BloggingStocks:  

Filed under: Newsletters, Bristol-Myers Squibb (BMY), Stocks to Buy

"Is Bristol-Myers Squibb (NYSE: BMY) ripe for a buyout?," asks growth expert Karim Rahemtulla. Here's an assessment from the investment director of Xcelerated Profits Report.


"I've predicted over the last several months that the larger pharmaceutical companies would be on the prowl for possible acquisitions.


"As it stands now, we probably haven't seen the last of such offers - and thanks to the previous two large mergers recently announced Merck acquiring Schering Plough and Pfizer buying Wyeth, many analysts are now speculating that Bristol-Myers Squibb could be next.

Continue reading Bristol-Myers: A good buyout target?

Bristol-Myers: A good buyout target? originally appeared on BloggingStocks on Tue, 17 Mar 2009 16:15:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments



Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati



 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch